Juan F. Blanco - Concepedia

Author

Juan F. Blanco

Also Known As

Blanco, Juan F., J Blanco, J F BLANCO, J F Blanco, J. Blanco, J. F. Blanco, J. F. Blanco Blanco, J.F. Blanco, Juan Francisco Blanco, Juan Blanco

106

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Universidad de Salamanca Instituto de Investigación Biomédica de Salamanca Complejo Hospitalario de Salamanca Centro de Investigación del Cáncer Instituto de Salud Carlos III

About

Juan F. Blanco is an author at Universidad de Salamanca specializing in medicine, cell biology, and regenerative medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	967
2	Biomedical Engineering	5	5	309
3	Engineering	4	4	262
4	Health Sciences	3	3	288
5	Public Health	1	1	30

Juan F. Blanco

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II) José María Lamo-Espinosa, Gonzalo Mora, Juan F. Blanco, Journal of Translational Medicine	2016	321
Isolation and Characterization of Mesenchymal Stromal Cells From Human Degenerated Nucleus Pulposus Juan F. Blanco, Fermín Sánchez‐Guijo, Sandra Muntión, Spine	2010	204
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry Roberto JP Magalhaes, María‐Belén Vídriales, Bruno Paiva, Haematologica	2012	170
Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors Mercedes Garayoa, Carlos Santamaría, Antonio García-Gómez, Leukemia Regenerative MedicineMesenchymal Stem CellsHematological MalignancyNormal DonorsMedicine	2009	158
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification Soraya Carrancio, Natalia López-Holgado, Fermín Sánchez‐Guijo, Experimental Hematology Regenerative MedicineTissue EngineeringCell SeparationEngineeringMedicine	2008	150
The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects Michelle A. Hurchla, Antonio García-Gómez, Mary C. Hornick, Leukemia Epoxyketone-based Proteasome InhibitorsMedicinal ChemistryBone-anabolic ActivityPharmacologyPharmacotherapy	2012	143
Risk factors for periprosthetic joint infection after total knee arthroplasty Juan F. Blanco, Agustín Díaz-Álvarez, Francisco R. Melchor, Archives of Orthopaedic and Trauma Surgery OsteoarthritisOrthopaedicsTotal Knee ArthroplastySurgeryJoint Replacement	2019	140
Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC) Luzalba Sanoja-Flores, Juan Flores‐Montero, Juan‐José Garcés, Blood Cancer Journal	2018	119
Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis José María Lamo-Espinosa, Juan F. Blanco, Mikel Sánchez, Journal of Translational Medicine	2020	110
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma Bruno Paiva, Martín Pérez‐Andrés, María‐Belén Vídriales, Leukemia Hematological MalignancyHematologyPathologyBone Marrow NichesMgus Vs Myeloma	2011	89

Page 1